WallStSmart

Medline Inc. Class A Common Stock (MDLN)vsSeagate Technology PLC (STX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medline Inc. Class A Common Stock generates 158% more annual revenue ($28.43B vs $11.01B). STX leads profitability with a 21.6% profit margin vs 4.1%. MDLN trades at a lower P/E of 31.3x. STX earns a higher WallStSmart Score of 76/100 (B+).

MDLN

Buy

52

out of 100

Grade: C-

Growth: 7.3Profit: 5.0Value: 6.3Quality: 6.8
Piotroski: 4/9

STX

Strong Buy

76

out of 100

Grade: B+

Growth: 7.3Profit: 9.0Value: 5.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDLNUndervalued (+68.8%)

Margin of Safety

+68.8%

Fair Value

$144.24

Current Price

$45.32

$98.92 discount

UndervaluedFair: $144.24Overvalued

Intrinsic value data unavailable for STX.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDLN1 strengths · Avg: 10.0/10
EPS GrowthGrowth
1258.0%10/10

Earnings expanding 1258.0% YoY

STX6 strengths · Avg: 9.7/10
PEG RatioValuation
0.5010/10

Growing faster than its price suggests

Operating MarginProfitability
35.7%10/10

Strong operational efficiency at 35.7%

Revenue GrowthGrowth
44.1%10/10

Revenue surging 44.1% year-over-year

EPS GrowthGrowth
108.3%10/10

Earnings expanding 108.3% YoY

Market CapQuality
$163.00B9/10

Large-cap with strong market position

Profit MarginProfitability
21.6%9/10

Keeps 22 of every $100 in revenue as profit

Areas to Watch

MDLN4 concerns · Avg: 3.0/10
P/E RatioValuation
31.3x4/10

Premium valuation, high expectations priced in

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
4.1%3/10

4.1% margin — thin

Free Cash FlowQuality
$-113.00M2/10

Negative free cash flow — burning cash

STX2 concerns · Avg: 2.0/10
P/E RatioValuation
69.0x2/10

Premium valuation, high expectations priced in

Price/BookValuation
367.1x2/10

Trading at 367.1x book value

Comparative Analysis Report

WallStSmart Research

Bull Case : MDLN

The strongest argument for MDLN centers on EPS Growth. Revenue growth of 14.8% demonstrates continued momentum.

Bull Case : STX

The strongest argument for STX centers on PEG Ratio, Operating Margin, Revenue Growth. Profitability is solid with margins at 21.6% and operating margin at 35.7%. Revenue growth of 44.1% demonstrates continued momentum.

Bear Case : MDLN

The primary concerns for MDLN are P/E Ratio, Return on Equity, Profit Margin. Thin 4.1% margins leave little buffer for downturns.

Bear Case : STX

The primary concerns for STX are P/E Ratio, Price/Book. A P/E of 69.0x leaves little room for execution misses.

Key Dynamics to Monitor

MDLN profiles as a value stock while STX is a growth play — different risk/reward profiles.

STX is growing revenue faster at 44.1% — sustainability is the question.

STX generates stronger free cash flow (953M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

STX scores higher overall (76/100 vs 52/100), backed by strong 21.6% margins and 44.1% revenue growth. MDLN offers better value entry with a 68.8% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medline Inc. Class A Common Stock

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. The company is headquartered in Northfield, Illinois.

Visit Website →

Seagate Technology PLC

TECHNOLOGY · COMPUTER HARDWARE · USA

Seagate Technology Holdings plc, an Irish public limited company (commonly referred to as Seagate) is an American data storage company.

Want to dig deeper into these stocks?